We recently partnered with Impact 4 Good to create a collaborative mural to serve as a symbol of resilience and encouragement for our local community. Each member of the Neumora team painted an individual square, contributing their art to the final product, which will hang in Boston's?@Pine Street Inn. Every person's mental health matters, and we're grateful to help spread hope and healing within our community.
关于我们
Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism of action where we can leverage our precision neuroscience approach. Our pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora is committed to addressing some of the most prevalent brain health disorders and transforming the standard of care for millions of patients living with brain diseases. Learn more about Neumora and career opportunities on our website below.
- 网站
-
https://www.neumoratx.com
Neumora的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Watertown，MA
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
获取路线
65 Grove Street, Suite 102
US，MA，Watertown，02472
Neumora员工
动态
-
Each year, our CEO Excellence Awards?recognize individuals or teams who exemplified relentless dedication to our mission throughout the year. In 2024, Zied Mjaied,?Erik Birkeneder,?Kevin Anderson, PhD,?Karin Knudson,?Sarah Carter,?Tien Dam,?Yashar Salek,?Xueping Zhang,?Shanna Myers,?Sarah Gilroy,?Devereux Laverdure and?Michael Ballard, PhD lived our values each day. Their contributions to Neumora are invaluable. Congratulations, team!?
-
We look forward to presenting at #JPM25 next week on Tuesday, January 14 at 8:15AM PT. Join us live via webcast at the link below to hear from CEO Henry Gosebruch and Head of R&D Rob Lenz, MD, PhD. https://lnkd.in/e98JzZ2u
-
-
Today we reported data from the Phase 3 KOASTAL-1 study of navacaprant in major depressive disorder. Read more here. https://lnkd.in/eCuntD2X
-
-
We are proud to support The Jed Foundation (JED) this holiday season and their mission to protect emotional health and prevent suicide for teens and young adults across the country. Our commitment to revolutionizing the way brain diseases are treated includes lifting up those in our community, and we’re grateful for the opportunity to support JED's invaluable work this year.
-
-
If you find the holiday season to be a challenging time of year, you are not alone. Supportive and educational resources are available. Find resources to support your navigation of this season from organizations like Substance Abuse and Mental Health Services Administration (SAMHSA). https://lnkd.in/eEDRctXH
-
-
Neumora is nominated for the #NEVYs24 Powerhouse Life Science Company of the Year! It is an honor to be recognized for our dedication to advancing new treatment options for people impacted by brain disease. We look forward to joining our fellow nominees at tomorrow’s New England Venture Capital Association annual NEVY awards ceremony.
-
-
Happy Thanksgiving! We are thankful for our clinical trial participants, clinicians, investigators and the entire Neumora team for their important roles in advancing new medicines for brain diseases. Our mission of reshaping the treatment landscape for diseases like #depression would not be possible without these individuals.?
-
-
Today, we reported Q3 #earnings and provided a business update. Read more below and listen in to our conference call at 8AM ET. https://lnkd.in/efrFW2tw
-